Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells
出版年份 2022 全文链接
标题
Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells
作者
关键词
-
出版物
MOLECULES
Volume 27, Issue 22, Pages 7968
出版商
MDPI AG
发表日期
2022-11-18
DOI
10.3390/molecules27227968
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
- (2022) Jang Mi Han et al. Cancers
- Atorvastatin inhibits the proliferation of MKN45-derived gastric cancer stem cells in a mevalonate pathway-independent manner
- (2022) Ye Seul Choi et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Pathogenetic Features and Current Management of Glioblastoma
- (2021) Hong-My Nguyen et al. Cancers
- The Role of CaMKII and ERK Signaling in Addiction
- (2021) Wenbin Jia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma
- (2021) Yu Jin Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
- (2020) Malak Hassn Mesrati et al. Cells
- Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies
- (2020) Xia-qing Xu et al. ACTA PHARMACOLOGICA SINICA
- CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
- (2019) Tanja K. Eggersmann et al. BIODRUGS
- Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
- (2019) Olivia G. Taylor et al. Frontiers in Oncology
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
- (2018) Shabierjiang JIAPAER et al. NEUROLOGIA MEDICO-CHIRURGICA
- BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca2+-CaMKII-dependent Akt/mTOR signaling pathway in normal and neoplastic B-lymphoid cells
- (2018) Xiaoqing Dong et al. CELLULAR SIGNALLING
- CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation
- (2017) X Ma et al. ONCOGENE
- Arcyriaflavin a, a cyclin D1–cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis
- (2017) Tomoko Hirakawa et al. Reproductive Biology and Endocrinology
- Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
- (2017) Dorota Lubanska et al. Drugs in research & development
- Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis
- (2016) Y Zhao et al. PROSTATE CANCER AND PROSTATIC DISEASES
- CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
- (2016) Meiou Dai et al. Scientific Reports
- Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells
- (2015) Shoujie Chai et al. Oncotarget
- The emerging role of CaMKII in cancer
- (2015) Yan-yang Wang et al. Oncotarget
- Berbamine Enhances the Antineoplastic Activity of Gemcitabine in Pancreatic Cancer Cells by Activating Transforming Growth Factor-β/Smad Signaling
- (2014) Xiaoli Jin et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment
- (2014) Zhi-Bo Hou et al. Asian Pacific Journal of Cancer Prevention
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
- (2014) Anil M Narasimha et al. eLife
- Calcium-Calmodulin-Dependent Protein Kinase II Isoforms Differentially Impact the Dynamics and Structure of the Actin Cytoskeleton
- (2013) Laurel Hoffman et al. BIOCHEMISTRY
- RETRACTED: Ca 2+ /calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer
- (2013) Shoujie Chai et al. CANCER LETTERS
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
- (2013) J. Rader et al. CLINICAL CANCER RESEARCH
- Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II
- (2013) Z. Meng et al. MOLECULAR CANCER THERAPEUTICS
- Erratum: Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2013) The Cancer Genome Atlas Research Network NATURE
- Delivery of Paclitaxel and Berbamine by Polymeric Carriers to Cure Gastric Cancer
- (2013) Lingjun Zhu et al. ONCOLOGY RESEARCH
- CaMKII , a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine
- (2012) Y. Gu et al. BLOOD
- Berbamine Protects the Heart From Ischemia/Reperfusion Injury by Maintaining Cytosolic Ca2+ Homeostasis and Preventing Calpain Activation
- (2012) Cai-Mei Zhang et al. CIRCULATION JOURNAL
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
- (2010) K. Michaud et al. CANCER RESEARCH
- A Novel Calmodulin Antagonist O-(4-Ethoxyl-Butyl)-Berbamine Overcomes Multidrug Resistance in Drug-Resistant MCF-7/ADR Breast Carcinoma Cells
- (2010) Rong Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells
- (2009) Yun Liang et al. ACTA PHARMACOLOGICA SINICA
- Suppression of human lung cancer cell growth and migration by berbamine
- (2009) Huiying Duan et al. CYTOTECHNOLOGY
- CaMKII knockdown attenuates H2O2-induced phosphorylation of ERK1/2, PKB/Akt, and IGF-1R in vascular smooth muscle cells
- (2009) Ali Bouallegue et al. FREE RADICAL BIOLOGY AND MEDICINE
- Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice
- (2009) Guan-Yu Wang et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Oct4 is expressed in human gliomas and promotes colony formation in glioma cells
- (2008) Zhanhui Du et al. GLIA
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation